This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
PMS Diltiazem CD (2014-02-21)
- Starting date:
- February 21, 2014
- Posting date:
- March 14, 2014
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-38219
Recalled products
- PMS Diltiazem CD, 180 mg
- PMS Diltiazem CD, 240 mg
Reason
This lot is being recalled following out-of-specification dissolution test results at the 30 hours time point after 9 months of shelf life.
Depth of distribution
Wholesalers and pharmacies in Canada
Affected products
-
PMS Diltiazem CD, 180 mg
DIN, NPN, DIN-HIM
DIN 02355760Dosage form
Controlled release capsule
Strength
- 180 mg
Lot or serial number
- KM 5010
Companies
- Recalling Firm
-
Pharmascience Inc.
100 - 6111 Royalmount Ave.
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
100 - 6111 Royalmount Ave.
Montreal
H4P 2T4
Quebec
CANADA
-
PMS Diltiazem CD, 240 mg
DIN, NPN, DIN-HIM
DIN 02355779Dosage form
Controlled release capsule
Strength
- 240 mg
Lot or serial number
- KM 5011
Companies
- Recalling Firm
-
Pharmascience Inc.
100 - 6111 Royalmount Ave.
Montreal
H4P 2T4
Quebec
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
100 - 6111 Royalmount Ave.
Montreal
H4P 2T4
Quebec
CANADA